Data presented at ASH 2025 suggest earlier-line use of cilta-cel leads to better outcomes in multiple myeloma because patients have fitter immune systems and less exhausted T cells, improving CAR T ...

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

A blood cancer diagnosis comes with a lot of new information and confusion ranging from blood tests and medical terminology to healthcare provider conversations and treatment considerations. Here’s ...

Recreation of CAR-T cells attacking a cancerous melanoma cell. Nemes Laszlo/Shutterstock Personalised medicine is already a reality in clinical practice, and CAR-T cell therapy is one of its most ...

Cold Spring Harbor Laboratory researchers reveal a groundbreaking approach using CAR T-cell therapy to rejuvenate aging ...

The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

Researchers have discovered a way to help aging intestines heal themselves using CAR T-cell therapy, targeting senescent ...

A new kind of cancer treatment is now available in Albany. Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the first person in ...

The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...